3137 results for «919»

Filter By

3137 results

Valve selection in urgent TAVI: evidence from small annulus studies - Hotline

16 Nov 2025 – From PCR London Valves 2025

This session presents cutting-edge research comparing self-expanding and balloon-expandable valves in urgent and emergent TAVI settings, with a focus on small aortic annuli. It includes data from the NAVULTRA and LANDMARK trials, featuring novel biomimetic balloon-expandable valves and early feasibility studies that shed light on valve...

Hotline - TAVI - Part 2

Comparative insights into QFR, FFR, and angiography

16 May 2024 – From EuroPCR 2024

This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...

Comparative insights into QFR, FFR, and angiography

Featured research - Aortic valve (Part 10)

26 Nov 2024 – From PCR London Valves 2024

Explore the latest research and insights in the field of aortic valve interventions through this featured research session. Discover cutting-edge studies on topics ranging from one-year outcomes after TAVI in different valve types to the impact of frailty and mobility on post-TAVI outcomes, and much more....

Featured research - Aortic valve (Part 10)

Highlights in valvular heart disease research - The year in EuroIntervention

17 Nov 2025 – From PCR London Valves 2025

This session highlights the most impactful research in valvular heart disease published in EuroIntervention in 2025. It reviews pivotal studies such as the ASCoP registry on complex PCI in severe aortic stenosis, the LANDMARK trial comparing Myval THV to other valves, and the D-PACE scoring system...

Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice

17 Nov 2025 – From PCR London Valves 2025

Discover the essential takeaways from the Myval THV series for improving TAVI outcomes. Learn from high-volume operators how pre-procedural planning, imaging, and sizing rationale guide optimal patient management. See step-by-step implantation of the next-gen Myval Octapro+, including the OctaAlign technique, and understand how precise deployment and...

Myval THV series - Optimise patient outcomes with novel design, data and daily clinical practice

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

Clinical decision based on coronary physiology: where do we stand in 2022?

17 May 2022 – From EuroPCR 2022

Watch this EuroPCR 2022 session if you want to know the latest updates on integrating physiology into optimal revascularization in the cathlab: improvements in wire-based technologies, QFR from online or offline CAG, CT angio coupled with FFR, and physiology-guided vs angio-guided revascularization in ACS.

Clinical decision based on coronary physiology: where do we stand in 2022?

Major Late-Breaking Trials from EuroPCR 2024

15 May 2024 – From EuroPCR 2024

This session presents the latest results from major late-breaking trials presented at EuroPCR 2024. It covers a one-month DAPT followed by 5-month ticagrelor monotherapy in acute coronary syndromes with DCB, the first TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid...

Major Late-Breaking Trials from EuroPCR 2024

Align for the future with next-generation balloon expandable THV technology

15 May 2024 – From EuroPCR 2024

In this session, explore the next-generation balloon-expandable Myval Octacor THV, focusing on its key features, procedural impact, and potential clinical benefits. Understand the procedural steps for planning and implanting it, especially for intermediate and extra-large sizes, using the Octalign technique. Learn about the unmet clinical need...

Align for the future with next-generation balloon expandable transcatheter heart valve technology

Diffuse multivessel disease

05 Jul 2019 – From AICT-AsiaPCR 2019

Diffuse multivessel disease

TAVI in bicuspid aortic valves: optimal technique and procedural refinement

21 Nov 2021 – From PCR London Valves 2021

Framed around a "live-in-a-box" case performed in Toulouse, the core of this session will be on procedural technique: how do you best perform a TAVI to get optimal outcomes in bicuspid anatomy? It will also focus on preprocedural planning, and in particular CT image analysis, and detail...

TAVI in bicuspid aortic valves: optimal technique and procedural refinement

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)

19 May 2021 – From EuroPCR 2021

Watch this session if you want to understand the role of invasive physiology in planning, guiding and evaluating your PCI strategy in MVD, to appreciate the role of intravascular imaging in the optimisation of PCI in such patients and to explore the expanding role of CT...

The role of physiology, CT and intracoronary imaging for the management of multivessel disease (Part 2)

TAVI in bicuspid aortic valve - Session with LIVE demonstration

19 May 2021 – From EuroPCR 2021

Watch this session if you want to review bicuspid aortic valve morphology, to discuss strategies for planning TAVI in patients with bicuspid aortic valve stenosis, and to learn procedural tips and tricks for optimal outcome.

This session was originally presented during EuroPCR 2021.

TAVI in bicuspid aortic

TAVI in challenging anatomical situations

21 May 2025 – From EuroPCR 2025

Delve into the latest advancements in TAVI for challenging anatomical situations. This session features insights from the NORTHOSTAVI registry, transcaval TAVI experiences, early discharge protocols following alternative access, and the application of intravascular lithotripsy to enable safe transfemoral valve replacement.

TAVI in challenging anatomical situations

How are we going to treat these sick patients presenting with pulmonary embolism?

21 May 2025 – From EuroPCR 2025

Address the urgent clinical question of how to treat patients presenting with pulmonary embolism across varying risk profiles. This session covers risk stratification and discusses interventional treatment options through detailed case analyses of intermediate and high-risk patients, providing practical guidance for individualized management.

How are we going to treat these sick patients presenting with pulmonary embolism?

Management of high-risk left main lesion

21 May 2025 – From EuroPCR 2025

Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.

Management of high-risk left main lesion

Transcatheter tricuspid valve replacement in the real world: current data and outcomes

21 May 2025 – From EuroPCR 2025

Explore current real-world data and outcomes of transcatheter tricuspid valve replacement (TTVR). This session reviews UK single-centre experiences, registry data, long-term right ventricular remodeling effects, safety in pacemaker patients, and AI-based CT screening for patient selection.

Transcatheter tricuspid valve replacement in the real world: current data and outcomes

Enhancing knowledge in diagnosis ANOCA

21 May 2025 – From EuroPCR 2025

Enhance your understanding of the diagnosis of ANOCA through advanced diagnostic techniques. Topics include coronary endothelial function assessment, exercise stress testing for microvascular dysfunction, acetylcholine-induced coronary responses, and the clinical implications of myocardial bridge in provocative testing.

Enhancing knowledge in diagnosis ANOCA

My worst PCI complication: how did I treat and could I have prevented it?

21 May 2025 – From EuroPCR 2025

Learn practical strategies to manage life-threatening PCI complications through real case studies. This session highlights techniques and devices employed to overcome complications, preventive measures, and safe outcome optimization during complex interventions.

My worst PCI complication: how did I treat and could I have prevented it?

Did danger shock change my practice?

21 May 2025 – From EuroPCR 2025

Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.

Did danger shock change my practice?
Didn’t find what you were looking for?